Seventeen placebo-controlled trials across seven antibodies yielded statistically significant but clinically small mean ...
Morning Overview on MSN
Major review finds limited benefits from new Alzheimer’s drugs hailed as breakthroughs
For the roughly 6.9 million Americans living with Alzheimer’s disease, the arrival of drugs that target amyloid plaques in ...
From July 4 to July 25, the University’s Division of Nutritional Sciences collaborated with the World Health Organization and Cochrane to host the eighth annual Summer Institute for Systematic Reviews ...
The Cochrane review did not include studies that have shown that face masks can reduce transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pictured here Olivia Palermo ...
In the fields of health and medicine, the Cochrane Database of Systematic Reviews may be the most trusted source of information. So when a massive Cochrane review finds that face-masking likely did ...
A new systematic review of 17 clinical trials found that drugs targeting amyloid beta proteins are likely to have no ...
People online are touting the results of a Cochrane review to incorrectly claim that it shows masks “don’t work” against the coronavirus. But the primary conclusion of the review is that it’s ...
‘Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease’ was published in the Cochrane Database of Systematic Reviews at ...
Today, Cochrane, a global independent network that gathers and summarizes the best evidence from research to help informed health decision-making, publishes an updated systematic review assessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results